-
Study aim
-
Surgical removal of impacted mandibular third molar is one of the most common surgical procedures in the oral cavity which usually accompanies with predictable sequels such as bleeding, swelling, pain and trismus .The aim of this study is to use mannitol and review its relationship with complications such as pain, swelling and trismus
-
Design
-
Randomized, double-blind, placebo-uncontrolled, single-center, phase one trial
-
Settings and conduct
-
In this split mouth study, 30 patients referred to Hamadan dental school with the age range of 64-16 years old with impacted mandibular third molars who had bilaterally and similar impacts are to be reviewed.
At least 4 weeks interval is considered between surgeries on either side to ensure recovery of the surgery. Surgery is implemented by maxillofacial surgeon but the variables were examined by student who is blind to use or non-use of mannitol and for this reason this study is blinded both on the patient and the inspector person
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Taking no medications and drugs, healthy patients with ASA 1 category, lack of allergy to local anesthesia, having bilateral mandibular third molar with similar impaction
Exclusion criteria: Poor oral hygiene, hypersensitivity to mannitol, smoking and alcohol abuse, pregnant and lactating mothers
-
Intervention groups
-
In this study, the side of the mandible where mannitol is infused will be considered as the treatment side while the opposite side is control that is randomly selected for each patient.
-
Main outcome variables
-
Pain level is recorded with VAS scale, swelling is evaluated by inflexible tape and trismus is measured by assessing the interincisal distance by digital caliper on 2, 4, 6 and 8 days